Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238.

circ_0000502 circular RNA miR-1238 osteosarcoma prognosis

Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
May 2019
Historique:
received: 11 10 2018
accepted: 31 10 2018
pubmed: 14 12 2018
medline: 14 12 2018
entrez: 8 12 2018
Statut: ppublish

Résumé

Growing evidence suggests that circular RNAs (circRNAs) play a significant role in regulating cancer initiation and metastasis. Osteosarcoma (OS) is a sophisticated disease with various genes activated or silenced. In this study, we defined a novel cancer-related circRNA, circ_0000502 in OS progression. qRT-PCR was conducted to detect its expression level in OS tissue samples and cell lines. In addition, the clinical significance of circ_0000502 was investigated. Afterwards, gain-of-function and loss-of-function in vitro assays were performed to detect the cell growth, apoptosis, migration, and invasion altered by circ_0000502 by CCK-8, clone-forming, flow cytometry, and transwell experiments. Xenograft study was performed to validate the in vitro data. The luciferase reporter assay was used to explore the mechanism of circ_0000502. Circ_0000502 was identified upregulated in both OS tissue specimens and cells. In addition, its expression predicts clinical severity and unfavorable prognosis in the 63 recruited patients with OS. Circ_0000502 facilitated cell proliferation, migration, and invasion in OS cells and inhibited cell apoptosis. The animal study further confirmed the in vitro results. For mechanism exploration, circ_0000502 could directly sponge microRNA (miR)-1238, and the oncogenic functions of circ_0000502 is partially dependent on its regulation of miR-1238 proved by rescue assays. In summary, this study might help to develop rational predictive and therapeutic target for patients with OS.

Identifiants

pubmed: 30525215
doi: 10.1002/jcb.28134
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8475-8482

Subventions

Organisme : Health and Family Planning Commission Research Project of Heilongjiang Province
ID : 2016-492

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Hongfei Qi (H)

Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Yue Sun (Y)

Department of Education, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Yuehong Jiang (Y)

Department of Clinical laboratory, Heilongjiang Provincial Hospital, Harbin, China.

Xiaolin Li (X)

Department of Oncology, Heilongjiang Provincial Hospital, Harbin, China.

Classifications MeSH